Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageWe offer a broad range of anesthesia systems and devices and breathing circuits, ventilation, respiratory and specialty airway products that maintain patients’ airways before, during and after surgery. Our primary Anesthesia & Respiratory products are: Temperature Management solutions systems are used in perioperative and critical care settings to help monitor and regulate patient temperature. Our primary Temperature Management products include:
In the company’s own words · 10-K filed Feb 19, 2026 · SEC EDGAR
Business segments
Q1 2026 · $530.2MThe company’s own SEC segment disclosure.
- US$315.5M60%
- EMEA$104.7M20%
- Asia Pacific$58.3M11%
- Otherforeigncountries$51.7M10%
ICU Medical, Inc. (ICUI) reported revenue of $530M in Q1 2026 (quarter ended March 31, 2026), down 12% from the same quarter a year earlier. That came with a gross margin of 39% and net income of $30M (5.7% of revenue). For the full year FY2025, revenue was $2.23B (−6.3% year on year) and net income $732K. Its largest region in 2026-Q1 was US at $316M, 60% of the disclosed total, just ahead of EMEA at 20%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
Ranks #23 of 27 by Smart Score